Table II. Clinical activity of napabucasin.
CR: Complete response; OS: overall survival; PFS: progression-free survival; SD: stable disease. One month=30.4375 days. *Patient was censored, neither progressive disease (PD) nor death were observed at the date of the last assessment of objective tumour response.